🇺🇸 erythomycin in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Asthma — 1 report (10%)
  2. Back Pain — 1 report (10%)
  3. Blood Pressure Increased — 1 report (10%)
  4. Bradycardia — 1 report (10%)
  5. Cardiac Arrest — 1 report (10%)
  6. Chest Discomfort — 1 report (10%)
  7. Chills — 1 report (10%)
  8. Cholecystectomy — 1 report (10%)
  9. Colectomy — 1 report (10%)
  10. Cystitis — 1 report (10%)

Source database →

Other Other approved in United States

Frequently asked questions

Is erythomycin approved in United States?

erythomycin does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for erythomycin in United States?

Assistance Publique - Hôpitaux de Paris is the originator. The local marketing authorisation holder may differ — check the official source linked above.